One America News Network OAN Staff Jenna Lee and Brooke Mallory
President Donald Trump announced a deal with Regeneron, a drug manufacturer and biotechnology company, to reduce the cost of its pharmaceutical products, marking a key milestone in the administration’s flagship drug-pricing initiative.
Under the terms of the agreement, the president stated that Regeneron will lower prices for its entire portfolio, including future releases, within the Medicaid system. Additionally, as confirmed via a White House Fact Sheet, the deal includes offering the cholesterol medication Praluent for $225 through the TrumpRx discount platform.
President Trump announces Regeneron has agreed to offer prescription drugs at heavily discounted “Most Favored Nation” pricing.
Watch OAN on Spectrum and YouTube TV for updates. pic.twitter.com/2tsg12bW1H
— One America News (@OANN) April 23, 2026
“It should be front page news,” Trump said while he announced the deal. “We should win the midterms, but it doesn’t work that way, unfortunately,” Trump added.
This deal emerges as the Trump administration prioritizes economic relief ahead of the November midterm elections, addressing the strain that rising costs for healthcare, fuel, and groceries have placed on American households.
…
Read Full Article Here… | One America News
Home | Caravan to Midnight (zutalk.com)
Be First to Comment